Sonio

Sonio

Signal active

Organization

Contact Information

Overview

Sonio is an AI-based support platform for fetal ultrasound, helping practitioners analyze and diagnose congenital malformations. Sonio combines the patient’s medical history, genetic and biological data, and ultrasound semiology to assist physicians on the path to the right diagnosis. It assists sonographers during prenatal screening scans, helping them ensure that they have not forgotten anything, take risk factors into account, and facilitate the sharing of images with patients and other health professionals.

About

Industries

Artificial Intelligence (AI), Health Care, Medical Device, Health Diagnostics

Founded

2020

Employees

11-50

Headquarters locations

Europe

Social

N/A

Profile Resume

Sonio headquartered in Europe, operates in the Artificial Intelligence (AI), Health Care, Medical Device, Health Diagnostics sector. The company focuses on Artificial Intelligence (AI) and has secured $1.9B in funding across 64 round(s). With a team of 11-50 employees, Sonio is actively contributing to advancements in Artificial Intelligence (AI). Their latest funding round, Series A - Sonio, raised $14.3M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Cecile Brosset

Cecile Brosset

Co-Founder & CEO

imagePlace Remi Besson

Remi Besson

Chief Scientific Officer and Co-Founder

Funding Rounds

Funding rounds

4

Investors

7

Lead Investors

0

Total Funding Amount

$30.2M

Details

3

Sonio has raised a total of $30.2M in funding over 3 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2022Seed5.2M
2022Seed8.0M
2023Early Stage Venture14.3M

Investors

Sonio is funded by 20 investors.

Investor NameLead InvestorFunding RoundPartners
Sonio-FUNDING ROUND - Sonio14.3M
Elaia-FUNDING ROUND - Elaia14.3M
Sonio-FUNDING ROUND - Sonio14.3M
La French Tech-FUNDING ROUND - La French Tech14.3M

Recent Activity

There is no recent news or activity for this profile.